Business Context and Reporting Period
This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc., as indicated in the metadata) on January 5, 2022. The report announces the consolidated financial results for the second quarter of fiscal year 2022, which ended on November 28, 2021.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. It serves solely as a notification that the results have been issued via a press release.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. The document explicitly states that the information in Item 2.02 and Exhibit 99.1 is furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the correct registrant name is Landec Corporation (Ticker: LNDC), not Lifecore Biomedical, Inc.
- Review Exhibit 99.1 (Press Release dated January 5, 2022) for actual financial figures and management commentary.
- Confirm the fiscal quarter end date of November 28, 2021 for accurate period comparison.
- Note that the financial data in this 8-K is not incorporated by reference into other filings unless expressly stated.